Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 6 months ago
Share
Phase 2b Study of GSK4532990 in Adults With NASH
246 patients around the world
Available in
Puerto Rico, Spain, United States, Mexico, Argentina
GlaxoSmithKline
246
Patients around the world
This study is for people with
Fatty liver/nash
Nonalcoholic steatohepatitis
Requirements for the patient
To 75 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
See details
Contact us
Contact us
Study
HORIZON
Sponsor
GlaxoSmithKline
Conditions
Nonalcoholic steatohepatitis
Requirements
To 75 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT05583344
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent